首页> 美国卫生研究院文献>Biomedicines >Correlations between Microbiota Bioactivity and Bioavailability of Functional Compounds: A Mini-Review
【2h】

Correlations between Microbiota Bioactivity and Bioavailability of Functional Compounds: A Mini-Review

机译:微生物群生物活性和功能化合物的生物利用度之间的关系:迷你审查。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Numerous studies have demonstrated the role of the microbiota in supporting the physiological functions, owing to its metabolomic component. The presence of biocomponents generally leads to the correction of the microbial pattern correlated with the reduction of oxidative pressure. This study aims to present the main processes that correlate the bioavailability and bioactivity of some functional components through the action of the human microbiota. The use of probiotics and prebiotics is an innovative manner involving alternatives that increase the bioavailability of certain natural or metabolic components has been proposed. Probiotic strains ( or ) may represent an intermediary for increasing the antioxidant bioactivity, and they may be administered in the form of a biomass enriched with functional compounds, such as phenolic acids. The limiting effect of gastrointestinal transit is, in several cases, the key to the biopharmaceutical value of new products (or supplements). The identification of newer ways of formulating supplements also involves the compatibility of different types of products, the testing of bioaccessibility, and the elimination of biotransformations.
机译:由于其代谢组学成分,许多研究证明了微生物群在支持生理功能中的作用。生物组分的存在通常导致与氧化压力降低相关的微生物模式的校正。这项研究旨在介绍通过人类微生物群的作用与某些功能成分的生物利用度和生物活性相关的主要过程。益生菌和益生元的使用是一种创新的方式,涉及增加某些天然或代谢成分的生物利用度的替代方法。益生菌菌株(或)可以代表增加抗氧化剂生物活性的中间体,它们可以以富含功能性化合物(如酚酸)的生物质形式施用。在某些情况下,胃肠道运输的限制作用是新产品(或补充剂)的生物制药价值的关键。确定新的补品配制方法还涉及不同类型产品的兼容性,生物可及性测试以及消除生物转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号